EcoDrugPlus

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSGACG00000007384
Gene Symbol: PTGS2B
1 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSGACG00000006582
Gene Symbol: PSMA1
1 Cross references
271 Possible Orthologues:

Proteasome 20s Subunit Alpha 2a

Ensembl ID : ENSGACG00000005705
Gene Symbol: PSMA2A
1 Cross references
278 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSGACG00000004038
Gene Symbol: PSMA3
1 Cross references
252 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSGACG00000007210
Gene Symbol: PSMA4
1 Cross references
199 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSGACG00000017471
Gene Symbol: PSMA4
1 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSGACG00000000332
Gene Symbol: PSMA5
1 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Alpha 6a

Ensembl ID : ENSGACG00000012527
Gene Symbol: PSMA6A
1 Cross references
229 Possible Orthologues:

Proteasome 20s Subunit Alpha 6b

Ensembl ID : ENSGACG00000005022
Gene Symbol: PSMA6B
1 Cross references
262 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSGACG00000013222
Gene Symbol: PSMA8
1 Cross references
183 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSGACG00000016151
Gene Symbol: PSMB1
1 Cross references
219 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSGACG00000018551
Gene Symbol: PSMB10
1 Cross references
172 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).